1. Pfizer Inc.
  2. Pfizer Inc. Ownership

Historical shareholding details of Doubleline Fortune 500 Equal Weight ETF holdings in Pfizer Inc. (PFE)

Monthly changes of Doubleline Fortune 500 Equal Weight ETF shareholding in Pfizer Inc. over the previous months

Month Name Total no. shares held Percent Holding
Jun 30, 2025 Doubleline Fortune 500 Equal Weight Etf 1,437 0.00%
Jun 27, 2025 Doubleline Fortune 500 Equal Weight Etf 1,437 0.00%
May 30, 2025 Doubleline Fortune 500 Equal Weight Etf 1,427 0.00%
Apr 30, 2025 Doubleline Fortune 500 Equal Weight Etf 1,141 0.00%
Apr 29, 2025 Doubleline Fortune 500 Equal Weight Etf 1,141 0.00%
Mar 31, 2025 Doubleline Fortune 500 Equal Weight Etf 1,147 0.00%
Mar 28, 2025 Doubleline Fortune 500 Equal Weight Etf 1,147 0.00%
Feb 28, 2025 Doubleline Fortune 500 Equal Weight Etf 1,216 0.00%
Feb 27, 2025 Doubleline Fortune 500 Equal Weight Etf 1,216 0.00%
Jan 31, 2025 Doubleline Fortune 500 Equal Weight Etf 1,216 0.00%
Jan 30, 2025 Doubleline Fortune 500 Equal Weight Etf 1,216 0.00%
Dec 31, 2024 Doubleline Fortune 500 Equal Weight Etf 1,216 0.00%
Dec 30, 2024 Doubleline Fortune 500 Equal Weight Etf 1,216 0.00%
Nov 27, 2024 Doubleline Fortune 500 Equal Weight Etf 1,154 0.00%
Oct 31, 2024 Doubleline Fortune 500 Equal Weight Etf 1,026 0.00%
Oct 30, 2024 Doubleline Fortune 500 Equal Weight Etf 1,026 0.00%
Sep 30, 2024 Doubleline Fortune 500 Equal Weight Etf 1,026 0.00%
Sep 27, 2024 Doubleline Fortune 500 Equal Weight Etf 1,026 0.00%
Aug 30, 2024 Doubleline Fortune 500 Equal Weight Etf 1,026 0.00%
Jul 31, 2024 Doubleline Fortune 500 Equal Weight Etf 960 0.00%
Jul 30, 2024 Doubleline Fortune 500 Equal Weight Etf 960 0.00%
Jun 28, 2024 Doubleline Fortune 500 Equal Weight Etf 960 0.00%
May 30, 2024 Doubleline Fortune 500 Equal Weight Etf 1,028 0.00%
Apr 30, 2024 - - 0.00%
Apr 29, 2024 Doubleline Fortune 500 Equal Weight Etf 1,028 0.00%
Mar 28, 2024 Doubleline Fortune 500 Equal Weight Etf 1,023 0.00%
Feb 29, 2024 Doubleline Fortune 500 Equal Weight Etf 1,023 0.00%

View all ownership details of Pfizer Inc.